MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.12466

Медицинская библиотека · Haematologica · 2008

Acute lymphoblastic leukemia in adolescents and young adults in Finland.

Usvasalo Anu, Räty Riikka, Knuutila Sakari, Vettenranta Kim, Harila-Saari Arja, Jantunen Esa, Kauppila Marjut, Koistinen Pirjo, Parto Katriina, Riikonen Pekka, Salmi Toivo T, Silvennoinen Raija, Elonen Erkki, Saarinen-Pihkala Ulla M

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Interest has recently been paid to adolescents and young adults with acute lymphoblastic leukemia, particularly because all reports so far published indicate that these patients have a better outcome when treated with pediatric rather than adult therapeutic protocols. There are different biological subtypes of acute lymphoblastic leukemia with distinct features and prognoses; the distribution of these subtypes is not well known among adolescents. We, therefore, studied acute lymphoblastic leukemia in adolescents and young adults aged 10 to 25 years in Finland.

DESIGN AND

METHODS

This population-based study included 225 consecutive patients aged 10-25 years diagnosed with acute lymphoblastic leukemia during 1990-2004. One hundred and twenty-eight patients (10-16 years) were treated with pediatric Nordic (NOPHO) protocols, and 97 patients (17-25 years) with Finnish Leukemia Group National protocols. We characterized the biological subtypes, clinical features and outcome of these patients.

RESULTS

For the whole cohort, the remission rate was 96%, 5-year event-free survival 62% and overall survival 72%. The 5-year event-free survival was 67% for the pediatric treatment group and 60% for the adult treatment group (p=n.s.). Patients with inferior outcome were those with a white blood cell count >or= 100 x 10(9)/L, the Philadelphia chromosome and MLL. Good prognostic features were TEL-AML1, hyperdiploidy, and pediatric intermediate risk stratification.

CONCLUSIONS

Unlike all previous studies, we found that the outcome of adolescents and young adults with acute lymphoblastic leukemia treated with pediatric or adult therapeutic protocols was comparable. The success of the adult acute lymphoblastic leukemia therapy emphasizes the benefit of central referral of patients to academic centers and adherence to research protocols.

Для цитирования: Usvasalo Anu, Räty Riikka, Knuutila Sakari, Vettenranta Kim, Harila-Saari Arja, Jantunen Esa, Kauppila Marjut, Koistinen Pirjo, Parto Katriina, Riikonen Pekka, Salmi Toivo T, Silvennoinen Raija, Elonen Erkki, Saarinen-Pihkala Ulla M. Acute lymphoblastic leukemia in adolescents and young adults in Finland.. Haematologica. 2008. DOI: 10.3324/haematol.12466.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.